Humacyte, Inc. (HUMA) vs vTv Therapeutics Inc. (VTVT)
A side-by-side comparison of Humacyte, Inc. and vTv Therapeutics Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
HUMA
Humacyte, Inc.
$0.48HealthcareDelayed quote: Oct 6, 2026, 4:00 PM EDT
VTVT
vTv Therapeutics Inc.
$30.03HealthcareDelayed quote: Oct 6, 2026, 4:00 PM EDT
Total return — HUMA vs VTVT
growth of $100 · dividends reinvested · last 6yHUMA -94.8% (-39.0%/yr)VTVT -63.5% (-15.5%/yr)VTVT compounded faster over this window
Log scale — wide-divergence pair
HUMA VTVT
HUMA vs VTVT: by the numbers
- •HUMA is the larger company ($80M vs $79M market cap).
- •Both run net losses; VTVT's is the smaller (-12.91% vs -4560.82% net margin).
- •HUMA grew revenue faster over the past five years (2.41% vs -18.12% CAGR).
Metrics side by side
Valuation
| Metric | HUMA | VTVT |
|---|---|---|
| P/S ratio | 37.86 | 2.13 |
| P/B ratio | 2.57 | 1.00 |
Profitability
| Metric | HUMA | VTVT |
|---|---|---|
| Gross margin | -736.46% | 0.00% |
| Operating margin | -5271.69% | 0.00% |
| Net margin | -4560.82% | -12.91% |
| ROE | -309.44% | -6.05% |
| ROIC | -90.27% | -11.48% |
Growth (annualized)
| Metric | HUMA | VTVT |
|---|---|---|
| Revenue CAGR (5Y) | 2.41% | -18.12% |
| Total return CAGR (5Y) | -45.73% | -13.55% |
Frequently asked
- Which has grown faster, HUMA or VTVT?
- Over the past five years, HUMA grew revenue faster — HUMA at a 2.41% CAGR versus VTVT at -18.12%.
- How have HUMA and VTVT total returns compared?
- Over the past 5 years, HUMA delivered -45.73% and VTVT delivered -13.55% annualized total return. Past performance doesn't predict future results.
Go deeper
Dig into the metrics
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.